GT’s cover story last February delved into the history of the bioinformatics industry in an attempt to find a success story somewhere in the drooping sector. The bioinformatics market has continued to perform below expectations. Of the companies mentioned in the article, several have seen changes in past months. NetGenics was acquired for a paltry $17 million by Lion Bioscience. Invitrogen snapped up InforMax for a more respectable $42 million.